Fadi Haddad, MD
NPI 1487322681ActiveIndividual· Internal Medicine, Hematology & Oncology· Houston, TX
Internal Medicine, Hematology & Oncology (MD) with Physicians Referral Service, practicing in Houston, Texas. Their prescriptions cost Medicare Part D more than their services did: $450,460 for 225 claims, against $66,148 paid for services in 2024. Astrazeneca Pharmaceuticals LP was the largest of 11 companies reporting payments in 2025, $16,734 in all, mostly consulting fees.
Overview
| NPI | 1487322681 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | Sep 1, 2021 |
| Last updated in NPPES | Jul 31, 2023 |
| Certified by provider | Jul 31, 2023 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Hematology & Oncology Primary | 207RH0003X | 47998 | TX |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Hematology/Oncology (TX) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 134 |
|---|---|
| Services billed | 666 across 14 procedure codes |
| Paid by Medicare | $66,148 |
Part D prescriptions in 2024
| Prescriptions (claims) | 225 · 230 30-day fills |
|---|---|
| Patients | 74 |
| Total drug cost | $450,460 |
| Generic share | 78% of claims |
Education and affiliations
| Graduation year | 2016 |
|---|---|
| Medicare specialty | Hematology/Oncology |
| Telehealth | Offers telehealth |
Medical group
- Physicians Referral ServiceHouston, TX · 2,765 clinicians
Industry payments (Open Payments)
- 2025$16,734 · 14 payments from 11 companies
- 2024$342.17 · 7 payments from 6 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Astrazeneca Pharmaceuticals LP | $5,740 | 1 |
| Glaxosmithkline, LLC. | $3,673 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $3,188 | 2 |
| Eli Lilly and Company | $1,563 | 1 |
| Lilly USA, LLC | $1,257 | 2 |
What the 2025 payments were for
- Consulting Fee$15,357 · 7 payments
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$1,000 · 1 payment
- Food and Beverage$329.24 · 5 payments
- Travel and Lodging$47.88 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other hematologist-oncologists in Houston
- 1013078294
- 1013956622
- 1023318284
- 1023343357
- 1023350105
- 1033478144
- 1053799304
- 1053845495
- 1073693339
- 1083707194
- 1104027549
- 1104089036
All 280 hematologist-oncologists in Houston · All hematologist-oncologists in Texas